Live feed
Filing
SC 13D/A
SC 13D/A0001493152-17-013875·Javelin Venture Partners GP, LLC
Schedule 13D ownership disclosure
Ritter Pharmaceuticals, Inc.
Security class unavailable · CUSIP: 767836109
Event date: 2017-10-03
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 14.4000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001493152-17-013875
- Form type
- SC 13D/A
- Filer
- Javelin Venture Partners GP, LLC
- CIK
- CIK 1510139
- Filed
- Nov 28, 2017
- Reporting period
- Oct 03, 2017
- Description
- Schedule 13D beneficial ownership